Home
>
National Drug Code (NDC)
>
Adenoscan
Adenoscan - 0469-0871-20 - (adenosine)
Drug Information of Adenoscan
| Product NDC: | 0469-0871 |
| Proprietary Name: | Adenoscan |
| Non Proprietary Name: | adenosine |
| Active Ingredient(s): | 3 mg/mL & nbsp; adenosine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Adenoscan
| Product NDC: | 0469-0871 |
| Labeler Name: | Astellas Pharma US, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020059 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19950518 |
Package Information of Adenoscan
| Package NDC: | 0469-0871-20 |
| Package Description: | 10 VIAL in 1 CARTON (0469-0871-20) > 20 mL in 1 VIAL |
NDC Information of Adenoscan
| NDC Code | 0469-0871-20 |
| Proprietary Name | Adenoscan |
| Package Description | 10 VIAL in 1 CARTON (0469-0871-20) > 20 mL in 1 VIAL |
| Product NDC | 0469-0871 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | adenosine |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19950518 |
| Marketing Category Name | NDA |
| Labeler Name | Astellas Pharma US, Inc. |
| Substance Name | ADENOSINE |
| Strength Number | 3 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |
